Author:
Keating Peter,Cambrosio Alberto
Publisher
Springer Science and Business Media LLC
Reference65 articles.
1. Kohli-Laven N, Bourret P, Keating P, Cambrosio A (2011) Cancer clinical trials in the era of genomic signatures: biomedical innovation, clinical utility, and regulatory-scientific hybrids. Soc Stud Sci 41:487–513
2. Taube SE, Clark GM, Dancey JE, McShane LM, Sigman CC, Gutman SI (2009) A perspective on challenges and issues in biomarker development and drug and biomarker codevelopment. J Natl Cancer Inst 101:1453–1463
3. Yap TA, Sandhu SK, Workman P, de Bono JS (2010) Envisioning the future of early anticancer drug development. Nat Rev Cancer 10:514–522
4. Pharmaceutical Research and Manufacturers of America (2011) Medicines in development for cancer. http://www.phrma.org/sites/default/files/1000/medicinesindevelopmentcancer2011_0.pdf . Accessed 20 May 2011
5. Karlberg JPE, Yao TJ, Yau HKC (2009) Industry sponsored oncology clinical trials. Clin Trial Magnifier 2:402–416
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献